A prospective study of psychological distress after prostate cancer surgery

Document Type

Journal Article

Publication Title

Psycho-Oncology

Publisher

Wiley

School

Exercise Medicine Research Institute

RAS ID

31055

Comments

Occhipinti, S., Zajdlewicz, L., Coughlin, G. D., Yaxley, J. W., Dunglison, N., Gardiner, R. A., & Chambers, S. K. (2019). A prospective study of psychological distress after prostate cancer surgery. Psycho‐Oncology, 28(12), 2389-2395. Available here

Abstract

Background: Men treated for prostate cancer experience heightened psychological distress and have an increased risk of suicide. Management of this distress and risk is crucial for quality urological care. Objective: To identify risk indicators for poorer trajectories of psychological adjustment and health-related quality of life (QoL) after surgery for localised prostate cancer. Design, Setting, and Participants: Patients were newly diagnosed with localised prostate cancer scheduled for surgical treatment. Patients were assessed at baseline (pre-surgery) and 6 weeks, 3 months, 6 months, 12 months, and 24 months post–surgery. Measurements: Assessment measures included sociodemographics, domain-specific and health-related QoL, and psychological distress. Mixed effects regression models were used to analyse the data. Results and Limitations: A total of 233 patients provided data for this analysis (Mage = 60 years, standard deviation [SD] = 4.02; MPSA = 7.37 ng/mL). At baseline, the prevalence of high psychological distress was 28% reducing to 21% at 24 months. Before treatment, younger age, more comorbidities, and worse bowel function were related to greater psychological distress; and younger age and better urinary, sexual, and bowel function were related to better health-related QoL. By contrast, for changes over time, only bowel function was important with better bowel function predicting decreasing psychological distress for men. Conclusions: Regular distress screening is indicated over the 24 months after surgery for localised prostate cancer. Care pathways for men with prostate cancer need also to respond to age-specific concerns and health problems associated with comorbidities in aging men. Focussed symptom control for bowel bother should be a priority.

DOI

10.1002/pon.5263

Access Rights

subscription content

Link to Full Text

Share

 
COinS